RESEARCH TRIANGLE PARK – Less than a year into her tenure as chief executive officer at GlaxoSmithKline, Emma Walmsley is rebuilding the company in her image.

Bloomberg news reports that Walmsley has “revamped” GSK’s top management, “replacing” some 50 of the firm’s top 125 managers.

Later, biotech news site BioCentury reported that it had confirmed the overhaul.

“GSK spokesperson Sarah Spencer told BioCentury the changes include several new hires, including former Novartis AG executives Tobias Hestler as consumer CFO and Christine Roth as head of oncology. Chief Procurement Officer Lisa Martin joined GSK’s team from Teva Pharmaceutical Industries Ltd., Marc Speichert came on as consumer chief digital officer from Google Inc. and Tony Wood joined GSK’s R&D team from Pfizer Inc.,” the website reported.

Bloomberg says Walmsely is recruiting from outside as well as inside GSK to refresh management.

“In changing 40 percent of Glaxo’s top executives, Walmsley has hired people from the outside while promoting others from within, the London-based company said Monday by email,” Bloomberg reports.
“She’s seeking to bring new ideas and skills, and to increase diversity to the team, according to the company.”
GSK employs several thousand people in the Triangle and at a production plant in Zebulon.